JNJ Stock Recent News

JNJ LATEST HEADLINES

JNJ Stock News Image - The Motley Fool

Axsome Therapeutics has multiple catalysts on the way. Johnson & Johnson is a bargain with its improving growth prospects.

The Motley Fool 2023 Apr 01
JNJ Stock News Image - The Motley Fool

Milvexian is a drug candidate under development by Bristol Myers and Johnson & Johnson. In a phase 2 clinical trial, milvexian produced encouraging results in preventing strokes.

The Motley Fool 2023 Mar 28
JNJ Stock News Image - Zacks Investment Research

Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.

Zacks Investment Research 2023 Mar 27
JNJ Stock News Image - The Motley Fool

Johnson & Johnson is spinning off its consumer health business this year as it pivots more toward its pharmaceutical and medtech businesses. Kellogg will spin off its North American cereal business, allowing it to focus more on snacks, which have generated better growth for it in recent years.

The Motley Fool 2023 Mar 22
JNJ Stock News Image - The Motley Fool

Blue chip stocks might give you a better balance of risk to potential reward than other investments. Taking advantage of catch-up contributions will let you put more into your retirement plans.

The Motley Fool 2023 Mar 19
JNJ Stock News Image - The Motley Fool

Johnson & Johnson has increased annual revenue for seven consecutive years. The company is pointing to revenue growth between 4.5% and 5.5% this year.

The Motley Fool 2023 Mar 18
JNJ Stock News Image - The Motley Fool

There's a lot of uncertainty in the market these days. Companies with strong financial profiles will be able to endure these challenging times.

The Motley Fool 2023 Mar 18
JNJ Stock News Image - Business Wire

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 18th to review first-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson's executive team.

Business Wire 2023 Mar 15
JNJ Stock News Image - Zacks Investment Research

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks Investment Research 2023 Mar 15
JNJ Stock News Image - InvestorPlace

Now more than ever, investors are looking for high-quality companies to invest in. There were some rumblings that we're in a new bull market, but the latest developments have been concerning.

InvestorPlace 2023 Mar 15
10 of 50